Health
SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY – Wiley
Click on the article title to read more.

Introduction: COVID-19 is thought to be more frequent and severe in patients with cancer. Lymphoma patients may be especially vulnerable, due to the immunodeficiency and immune dysregulation caused by the lymphoma itself and the antitumor treatments. This…
Continue Reading
-
General10 hours ago
Australian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News20 hours ago
Rainbow Beach surfer’s untold 7/7 story
-
Noosa News10 hours ago
Unvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
Noosa News12 hours ago
Woman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland